> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Ekso Bionics’ Exoskeleton Cleared for Multiple Sclerosis
- URL: https://www.fdaweb.com/ekso-bionics-exoskeleton-cleared-for-multiple-sclerosis/
- Published: 2022-06-13T12:00:00.000Z
- Updated: 2026-09-14T17:48:26.000Z
- Author: David McFarland
- Tags: Devices, #legacy-id-D5152052

FDA has cleared an Ekso Bionics Holdings 510(k) to market its EksoNR robotic exoskeleton for use with multiple sclerosis patients. The device was cleared for stroke and spinal cord injury rehabilitation in 2016, and acquired brain injury in 2020\. It features software to customize motor support strength for various impairment levels, from full assistance to patient-initiated movement. It also has sensors and software that continuously monitor and regulate leg movement to minimize compensatory gait patterns, Ekso says.